The global weight loss and obesity management industry size is expected to have a net worth of US$ 3.68 billion in 2022 and to grow at a CAGR of 5.2% to reach US$ 4.99 billion by value by 2028. One of the most urgent health issues of our time is being addressed by the weight …
Monthly Archives: December 2023
Global Generic Oncology Drugs Industry is on the brink of considerable expansion, with an anticipated value of US$ 34.8 Billion by 2028
Sales of generic oncology drugs industry size are anticipated to reach US$ 24.5 billion in 2022 and US$ 34.8 billion by the end of 2028, rising at a 6% CAGR. The main factor causing cancer in people is the rise in tobacco use and smoking. The human body is vulnerable to cancer due to secondary …
Global Sleep Aid Devices Industry is poised for substantial growth, with projections showing a 6.9% CAGR by 2032 tracked by FMI
According to projections, the global sleep aid devices industry demand will be worth roughly US$ 68354.36 million in 2022 and US$ 133211.98 million by 2032. The market is anticipated to expand at a 6.9% CAGR from 2022 to 2032. As the prevalence of sleep problems and insomnia has continued to climb, the Sleep Aid Devices …
Global Oral Antiseptics Industry in North America and East Asia anticipates a stable 4.7% CAGR till 2028 | FMI
The global oral antiseptics industry size is set to witness an unprecedented surge, with projections indicating a substantial rise from a valued US$ 2.47 billion in 2022 to an estimated US$ 3.24 billion by 2028. This anticipated growth is substantiated by a promising Compound Annual Growth Rate (CAGR) of 4.7%. The Oral Antiseptics Market has …
Sun’s Power Unveiled: Navigating the Radiant Growth of the Industrial Solar Water Heaters Market Through 2032
The Industrial Solar Water Heaters Market report, published by Future Market Insights, an organization with ESOMAR Certified Market Research and Consulting Firm, provides insights and analysis into the Industrial Solar Water Heaters market. It outlines the scope and content of the research, covering driving factors, market size, and forecast data for Industrial Solar Water Heaters. The report …
Rising Interest in Natural Colorants Propels Canthaxanthin Market Toward an Anticipated Worth of US$ 245.3 Million by 2033
In 2023, the size of the global canthaxanthin market is anticipated to surpass a valuation of US$ 125.9 million. It is anticipated to expand even more between 2023 and 2033 at a CAGR of 6.9%. By the end of 2033, it’s expected to reach US$ 245.3 million. The growth of the convenience and processed food sectors is one of the …
Over-the-Counter Pain Medication Industry Poised for Skyrocketing Success, Targeting a US$ 27.7 Billion Valuation by 2028-FMI Report
The over-the-counter (OTC) painkillers industry is expected to reach US$ 21.8 billion in 2022, according to a recent analysis by Future Market Insights (FMI). The growth of this market is expected to be impacted by changing perceptions of generic prescription medications. The analysis projects that market sales would rise at a faster 4.1% annual pace …
Global Brain Monitoring Systems Industry is estimated at US$ 8.5 Billion by 2033, is highlighted by FMI
The global brain monitoring systems industry size is poised for substantial growth according to recent projections, with an anticipated rise at a Compound Annual Growth Rate (CAGR) of 5.5% from 2023 to 2033. These findings, unveiled in a comprehensive market analysis report, forecast the market to soar from a value of US$ 5.0 billion in …
United States Beetroot Supplement Market Expected to Reach US$ 317.9 Million by 2033, as Predicted by Future Market Insights, Inc.
According to Future Market Insights (FMI), the United States beetroot supplement market value is expected to increase from US$ 143.5 million in 2023 to US$ 317.9 million by 2033. Over the projection period (2023 to 2033), sales of beetroot supplements in the United States are likely to rise at 8.3% CAGR. Growth in the market is driven by a desire for healthier …
Seasonal Affective Disorder Therapeutics Industry Radiant Growth on the Horizon, Anticipated to Achieve US$ 1.1 Billion by 2028-FMI Report
The research states that SSRIs, or selective serotonin reuptake inhibitors, are often prescribed drugs for the treatment of seasonal affective disorder. In the market for seasonal affective disorder treatments industry, there are numerous branded and generic drugs accessible, however Buproban and Citalopram continue to sell at a comparatively greater rate. FMI attributes this supremacy to …